Skip to content
Products
TrueView 100 Pro
Navigator 2.0
Navigator 2.0
Navigator Sterilization
MarginProbe
MarginProbe Technology
Clinical Data
Partial Mastectomy
Lumpectomy Surgery
Ductal Carcinoma in Situ (DCIS)
Lumpectomy Margins
Patient Stories
HEMOBLAST Bellows
Clinical Data
Economic Value
Surgical Videos
CoPilot VL+
About
Careers
News
Products
TrueView 100 Pro
Navigator 2.0
Navigator 2.0
Navigator Sterilization
MarginProbe
MarginProbe Technology
Clinical Data
Partial Mastectomy
Lumpectomy Surgery
Ductal Carcinoma in Situ (DCIS)
Lumpectomy Margins
Patient Stories
HEMOBLAST Bellows
Clinical Data
Economic Value
Surgical Videos
CoPilot VL+
About
Careers
News
CONTACT
Intraoperative Tissue Characterization Probe as a Potential Tool for Surgical Margin Assessment.
June 6, 2005
/
Clinical Data
[vc_row][vc_column][vc_column_text]
View Study
[/vc_column_text][/vc_column][/vc_row]
Posted in
Clinical Data
Posts navigation
← Twenty-Year Follow-Up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy Plus Irradiation for the Treatment of Invasive Breast Cancer
Intraoperative Tissue Characterization Probe as a Potential Tool for Surgical Margin Assessment →